Literature DB >> 25849426

Antiobesity strategy targets energy economy safeguards.

Michel Vivaudou1, André Terzic2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25849426      PMCID： PMC4395794          DOI： 10.1038/mt.2015.39

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

1.  Disruption of KATP channel expression in skeletal muscle by targeted oligonucleotide delivery promotes activity-linked thermogenesis.

Authors:  Siva Rama Krishna Koganti; Zhiyong Zhu; Ekaterina Subbotina; Zhan Gao; Ana Sierra; Manuel Proenza; Liping Yang; Alexey Alekseev; Denice Hodgson-Zingman; Leonid Zingman
Journal:  Mol Ther       Date:  2015-02-04       Impact factor: 11.454

2.  ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits.

Authors:  Garvan C Kane; Atta Behfar; Satsuki Yamada; Carmen Perez-Terzic; Fearghas O'Cochlain; Santiago Reyes; Petras P Dzeja; Takashi Miki; Susumu Seino; Andre Terzic
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

Review 3.  ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart.

Authors:  Alexey E Alekseev; Denice M Hodgson; Amy B Karger; Sungjo Park; Leonid V Zingman; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-04-14       Impact factor: 5.000

Review 4.  SUR, ABC proteins targeted by KATP channel openers.

Authors:  Christophe Moreau; Anne-Lise Prost; Renaud Dérand; Michel Vivaudou
Journal:  J Mol Cell Cardiol       Date:  2005-02-19       Impact factor: 5.000

Review 5.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

Review 6.  New pharmacological approaches for obesity management.

Authors:  Christian F Rueda-Clausen; Raj S Padwal; Arya M Sharma
Journal:  Nat Rev Endocrinol       Date:  2013-06-11       Impact factor: 43.330

7.  Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues.

Authors:  Paul A Morcos; Yongfu Li; Shan Jiang
Journal:  Biotechniques       Date:  2008-12       Impact factor: 1.993

Review 8.  Antiobesity pharmacotherapy: new drugs and emerging targets.

Authors:  G W Kim; J E Lin; E S Blomain; S A Waldman
Journal:  Clin Pharmacol Ther       Date:  2013-10-08       Impact factor: 6.875

9.  Sarcolemmal ATP-sensitive K(+) channels control energy expenditure determining body weight.

Authors:  Alexey E Alekseev; Santiago Reyes; Satsuki Yamada; Denice M Hodgson-Zingman; Srinivasan Sattiraju; Zhiyong Zhu; Ana Sierra; Marina Gerbin; William A Coetzee; David J Goldhamer; Andre Terzic; Leonid V Zingman
Journal:  Cell Metab       Date:  2010-01       Impact factor: 27.287

Review 10.  Human K(ATP) channelopathies: diseases of metabolic homeostasis.

Authors:  Timothy M Olson; Andre Terzic
Journal:  Pflugers Arch       Date:  2009-12-24       Impact factor: 3.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.